Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Check-Cap Ltd. stock logo
CHEK
Check-Cap
$0.68
$0.74
$0.56
$3.04
$3.97M0.1928,454 shs9,285 shs
Dynatronics Co. stock logo
DYNT
Dynatronics
$0.09
$0.08
$0.06
$0.24
$1.19M0.497,232 shs1,932 shs
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
$4.44
+1.4%
$4.97
$2.90
$99.40
$3.30M-0.1897,830 shs24,950 shs
Quoin Pharmaceuticals, Ltd. Sponsored ADR stock logo
QNRX
Quoin Pharmaceuticals
$7.37
+2.6%
$8.34
$5.01
$54.95
$4.22M1.444,358 shs1,833 shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Check-Cap Ltd. stock logo
CHEK
Check-Cap
-1.31%+12.42%-12.95%-25.16%-64.26%
Dynatronics Co. stock logo
DYNT
Dynatronics
0.00%+12.22%+2.27%+10.57%-40.40%
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
+4.78%-15.61%-45.72%+36.45%-99.91%
Quoin Pharmaceuticals, Ltd. Sponsored ADR stock logo
QNRX
Quoin Pharmaceuticals
+1.04%+0.61%-19.45%-5.32%-60.92%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Check-Cap Ltd. stock logo
CHEK
Check-Cap
0.4227 of 5 stars
0.03.00.00.01.90.00.6
Dynatronics Co. stock logo
DYNT
Dynatronics
N/AN/AN/AN/AN/AN/AN/AN/A
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
3.1382 of 5 stars
3.54.00.00.03.30.01.3
Quoin Pharmaceuticals, Ltd. Sponsored ADR stock logo
QNRX
Quoin Pharmaceuticals
1.1522 of 5 stars
0.04.00.00.02.90.80.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Check-Cap Ltd. stock logo
CHEK
Check-Cap
0.00
N/AN/AN/A
Dynatronics Co. stock logo
DYNT
Dynatronics
0.00
N/AN/AN/A
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
3.00
Buy$50.001,026.13% Upside
Quoin Pharmaceuticals, Ltd. Sponsored ADR stock logo
QNRX
Quoin Pharmaceuticals
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Check-Cap Ltd. stock logo
CHEK
Check-Cap
N/AN/AN/AN/A$4.05 per shareN/A
Dynatronics Co. stock logo
DYNT
Dynatronics
$33.60M0.04N/AN/A$0.57 per share0.16
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
N/AN/AN/AN/A$4.77 per shareN/A
Quoin Pharmaceuticals, Ltd. Sponsored ADR stock logo
QNRX
Quoin Pharmaceuticals
N/AN/AN/AN/A$4.34 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Check-Cap Ltd. stock logo
CHEK
Check-Cap
-$17.57M-$3.00N/AN/AN/AN/AN/AN/A
Dynatronics Co. stock logo
DYNT
Dynatronics
-$2.70M-$0.78N/AN/A-8.35%-41.81%-9.56%9/22/2025 (Estimated)
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
-$11.51M-$172.04N/AN/AN/AN/A-140.96%-106.14%N/A
Quoin Pharmaceuticals, Ltd. Sponsored ADR stock logo
QNRX
Quoin Pharmaceuticals
-$8.96M-$41.45N/AN/AN/AN/A-210.50%-99.41%N/A

Latest DYNT, QNRX, NDRA, and CHEK Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2025Q2 2025
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
-$2.27-$1.71+$0.56-$1.71N/AN/A
8/7/2025Q2 2025
Quoin Pharmaceuticals, Ltd. Sponsored ADR stock logo
QNRX
Quoin Pharmaceuticals
-$6.83-$6.28+$0.55-$6.28N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Check-Cap Ltd. stock logo
CHEK
Check-Cap
N/AN/AN/AN/AN/A
Dynatronics Co. stock logo
DYNT
Dynatronics
N/AN/AN/AN/AN/A
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
N/AN/AN/AN/AN/A
Quoin Pharmaceuticals, Ltd. Sponsored ADR stock logo
QNRX
Quoin Pharmaceuticals
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Check-Cap Ltd. stock logo
CHEK
Check-Cap
N/AN/AN/A
Dynatronics Co. stock logo
DYNT
Dynatronics
0.25
1.21
0.60
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
N/A
3.85
3.85
Quoin Pharmaceuticals, Ltd. Sponsored ADR stock logo
QNRX
Quoin Pharmaceuticals
N/A
1.96
1.96

Institutional Ownership

CompanyInstitutional Ownership
Check-Cap Ltd. stock logo
CHEK
Check-Cap
1.07%
Dynatronics Co. stock logo
DYNT
Dynatronics
4.18%
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
1.19%
Quoin Pharmaceuticals, Ltd. Sponsored ADR stock logo
QNRX
Quoin Pharmaceuticals
8.63%

Insider Ownership

CompanyInsider Ownership
Check-Cap Ltd. stock logo
CHEK
Check-Cap
0.48%
Dynatronics Co. stock logo
DYNT
Dynatronics
7.98%
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
0.04%
Quoin Pharmaceuticals, Ltd. Sponsored ADR stock logo
QNRX
Quoin Pharmaceuticals
13.46%
CompanyEmployeesShares OutstandingFree FloatOptionable
Check-Cap Ltd. stock logo
CHEK
Check-Cap
805.85 million5.82 millionNot Optionable
Dynatronics Co. stock logo
DYNT
Dynatronics
20013.18 million8.11 millionNot Optionable
ENDRA Life Sciences Inc. stock logo
NDRA
ENDRA Life Sciences
20750,000753,000Not Optionable
Quoin Pharmaceuticals, Ltd. Sponsored ADR stock logo
QNRX
Quoin Pharmaceuticals
4590,000509,000Not Optionable

Recent News About These Companies

Quoin (QNRX) Q2 Loss Beats Estimates
Quoin Pharmaceuticals Provides Product Portfolio Update
Quoin Pharmaceuticals, Ltd. (QNRX) - Yahoo Finance

New MarketBeat Followers Over Time

Media Sentiment Over Time

Check-Cap stock logo

Check-Cap NASDAQ:CHEK

$0.68 0.00 (0.00%)
Closing price 03:49 PM Eastern
Extended Trading
$0.67 -0.01 (-1.03%)
As of 04:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.

Dynatronics stock logo

Dynatronics NASDAQ:DYNT

$0.09 0.00 (0.00%)
As of 12:08 PM Eastern

Dynatronics Corporation, a medical device company, designs, manufactures, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States. The company offers orthopedic soft bracing products include cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products. It also offers physical therapy and rehabilitation products, which include therapeutic modality devices comprising electrotherapy, ultrasound, phototherapy, traction, hot and cold therapy, and electrodes; and power and manually operated treatment tables, mat platforms, work tables, parallel bars, training stairs, weight racks, and other related equipment. In addition, the company manufactures and distributes clinical supplies, including exercise bands and tubing, lotions and gels, orthopedic bracings, paper products, and other related supplies. It markets its products under the Dynatron, Dynatron Solaris, Dynaheat, BodyIce, Powermatic, Bird & Cronin, Physician's Choice, Hausmann, PROTEAM, and Mammoth brands. The company sells its products to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and retail distributors and equipment manufacturers. It also exports its products in Asia, Latin America, and the Middle East. Dynatronics Corporation was founded in 1979 and is headquartered in Eagan, Minnesota.

ENDRA Life Sciences stock logo

ENDRA Life Sciences NASDAQ:NDRA

$4.44 +0.06 (+1.37%)
Closing price 04:00 PM Eastern
Extended Trading
$4.43 -0.01 (-0.11%)
As of 05:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.

Quoin Pharmaceuticals stock logo

Quoin Pharmaceuticals NASDAQ:QNRX

$7.36 +0.19 (+2.58%)
Closing price 03:58 PM Eastern
Extended Trading
$7.24 -0.13 (-1.70%)
As of 05:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Quoin Pharmaceuticals, Ltd., a clinical stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases. Its lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). The company is also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat NS; and QRX008 for the treatment of scleroderma. It has a research agreement with Queensland University of Technology; a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; and a Master Service Agreement with Therapeutics Inc. The company was founded in 2018 and is based in Ashburn, Virginia.